A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension

• Status: Completed
• Trial end date: 2005-11-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the safety and efficacy of an aliskiren-based regimen to a lisinopril-based regimen in the treatment of severe hypertension

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis
• Treatments: Lisinopril

Criteria

Inclusion Criteria

• Patients with essential severe hypertension Exclusion Criteria

• History or evidence of a secondary form of hypertension

• History of hypertensive encephalopathy or cerebrovascular accident.

• Diabetic patients requiring insulin Other protocol-defined inclusion/exclusion criteria also apply